Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy

Circulation

Volumn 112, Issue 18, 2005, Pages 2821-2825

  Nazarian, Saman ^a   Bluemke, David A ^a   Lardo, Albert C ^a   Zviman, Menekhem M ^a   Watkins, Stanley P ^a   Dickfeld, Timm L ^a   Meininger, Glenn R ^a   Roguin, Ariel ^a   Calkins, Hugh ^a   Tomaselli, Gordon F ^a   Weiss, Robert G ^a   Berger, Ronald D ^a   Lima, João A C ^a   Halperin, Henry R ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Electrophysiology; Magnetic resonance imaging; Tachyarrhythmias

Indexed keywords

ADULT; APPARATUS; ARTICLE; CALCULATION; CARDIOMYOPATHY; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; IMAGING SYSTEM; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SCAR; STEADY STATE; SUDDEN DEATH; THICKNESS;

CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 27844487622     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.549659     Document Type: Article

References (19)

1. van der Burg AE, Bax JJ, Boersma E, Pauwels EK, van der Wall EE, Schalij MJ. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation. 2003;108:1954-1959.
2. Tscholakoff D, Higgins CB, Sechtem U, McNamara MT. Occlusive and reperfused myocardial infarcts: effect of Gd-DTPA on ECG-gated MR imaging. Radiology. 1986;160:515-519.
3. de Roos A, van Rossum AC, van der Wall E, Postema S, Doorabos J, Matheijssen N, van Dijkman PR, Visser FC, van Voorthuisen AE. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology. 1989;172:717-720.
4. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation. 1995;92:1117-1125.
5. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
6. Vignaux O, Dhote R, Duboc D, Blanche P, Devaux JY, Weber S, Legmann P. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr. 2002;26:762-767.
7. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45:1104-1108.
8. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59.
9. Wellens HJ, Duren DR, Lie KI. Observations on mechanisms of ventricular tachycardia in man. Circulation. 1976;54:237-244.
10. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43:1834-1842.
11. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
12. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ, Gatzoulis MA, Kilner PJ. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. 2005;111:2091-2098.
13. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108:704-710.
14. Brembilla-Perrot B, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J. 1991;121(pt 1):1124-1131.
15. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. W Engl J Med. 2004;350:2140-2150.
16. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO 3rd, Bonow RO, Maron BJ, Epstein SE. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: a consecutive analysis in 155 patients. Circulation. 1989;80:1259-1268.
17. Leite LR, Fenelon G, Simoes A Jr, Silva GG, Friedman PA, de Paola AA, Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol. 2003;14:567-573.
18. Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E, Gomes JA, Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol. 1991;18:937-943.
19. Lopera G, Stevenson WG, Soejima K, Maisel WH, Koplan B, Sapp JL, Satti SD, Epstein LM. Identification and ablation of three types of ventricular tachycardia involving the His-Purkinje system in patients with heart disease. J Cardiovasc Electrophysiol. 2004;15:52-58.